Drug Shortage Report for SODIUM CHLORIDE INJECTION USP

Last updated on 2023-01-20 History
Report ID 151759
Drug Identification Number 00037796
Brand name SODIUM CHLORIDE INJECTION USP
Common or Proper name SODIUM CHLORIDE INJECTION USP
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) SODIUM CHLORIDE
Strength(s) 9MG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS INTRAVENOUS INTRAPERITONEAL INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAPERITONEAL INTRAMUSCULAR
Packaging size 25 x 10mL vial
ATC code B05XA
ATC description I.V. SOLUTION ADDITIVES
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2022-01-01
Estimated end date
Actual end date 2022-08-31
Shortage status Resolved
Updated date 2023-01-20
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v16 2023-01-20 English Compare
v15 2022-09-01 English Compare
v14 2022-08-31 French Compare
v13 2022-08-31 English Compare
v12 2022-06-22 French Compare
v11 2022-06-22 English Compare
v10 2022-06-01 French Compare
v9 2022-06-01 English Compare
v8 2022-05-06 French Compare
v7 2022-05-06 English Compare
v6 2022-02-17 French Compare
v5 2022-02-17 English Compare
v4 2022-01-21 English Compare
v3 2022-01-02 English Compare
v2 2021-12-22 French Compare
v1 2021-12-22 English Compare

Showing 1 to 16 of 16